EyePoint, Inc. - Common Stock (NQ:EYPT)

14.81 +0.18 (+1.23%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 16, 2026 Add to My Watchlist

Price and Volume

Volume	588,192
Open	14.63
Bid (Size)	14.65 (2,000)
Ask (Size)	14.80 (700)
Prev. Close	14.63
Today's Range	14.51 - 14.87
52wk Range	5.300 - 19.11
Shares Outstanding	34,984,044
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know? ↗

March 16, 2026

This biotech develops Nanobody-based therapies targeting chronic inflammatory diseases in dermatology and rheumatology markets.

Via The Motley Fool

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal ↗

March 16, 2026

Arcellx develops cell-based immunotherapies for cancer, leveraging proprietary platforms to address high unmet needs in oncology.

Via The Motley Fool

Performance

YTD	-15.3%	-15.3%
1 Month	+6.5%	+6.5%
3 Month	-6.5%	-6.5%
6 Month	+28.2%	+28.2%
1 Year	+166.8%	+166.8%

More News

Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch ↗

March 16, 2026

Via The Motley Fool

EyePoint Inc (NASDAQ:EYPT) Stock Falls on Q4 Earnings and Revenue Miss ↗

March 04, 2026

Via Chartmill

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Analyst Expectations For EyePoint Pharmaceuticals's Future ↗

May 29, 2025

Via Benzinga

This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter ↗

March 16, 2026

Via The Motley Fool

This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment ↗

March 15, 2026

Via The Motley Fool

EyePoint (EYPT) Q4 2025 Earnings Call Transcript ↗

March 04, 2026

Via The Motley Fool

Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data

February 16, 2026

Via MarketMinute

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

January 22, 2026

Via MarketMinute

Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles

January 08, 2026

Via MarketMinute

The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens

January 02, 2026

Via MarketMinute

The Small-Cap Renaissance: Why 2026 is the Year of the Russell 2000 and XSU

January 01, 2026

Via MarketMinute

The 2026 Horizon: Technical Breakouts Signal a Sustained Bull Run in AI and Energy

December 31, 2025

Via MarketMinute

Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? ↗

December 22, 2025

Via The Motley Fool

EyePoint (EYPT) Q3 2025 Earnings Call Transcript ↗

November 05, 2025

Via The Motley Fool

EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Shares Drop on Q3 Earnings and Revenue Miss ↗

November 05, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 15, 2025

Via Benzinga

EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study ↗

October 15, 2025

Via Benzinga

EyePoint (EYPT) Q2 Revenue Drops 44% ↗

August 06, 2025

Via The Motley Fool

EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Q2 2025 Earnings Miss Estimates as Shares Drop 4.5% Pre-Market ↗

August 06, 2025

Via Chartmill

Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals ↗

June 17, 2025

Via Benzinga

Breakout Momentum Plays You May Not Know About

June 06, 2025

Via MarketBeat

Frequently Asked Questions

Is EyePoint, Inc. - Common Stock publicly traded?

Yes, EyePoint, Inc. - Common Stock is publicly traded.

What exchange does EyePoint, Inc. - Common Stock trade on?

EyePoint, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for EyePoint, Inc. - Common Stock?

The ticker symbol for EyePoint, Inc. - Common Stock is EYPT on the Nasdaq Stock Market

What is the current price of EyePoint, Inc. - Common Stock?

The current price of EyePoint, Inc. - Common Stock is 14.81

When was EyePoint, Inc. - Common Stock last traded?

The last trade of EyePoint, Inc. - Common Stock was at 04/16/26 04:00 PM ET

What is the market capitalization of EyePoint, Inc. - Common Stock?

The market capitalization of EyePoint, Inc. - Common Stock is 518.11M

How many shares of EyePoint, Inc. - Common Stock are outstanding?

EyePoint, Inc. - Common Stock has 518M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.